A Further Breakdown Of Home-Based Care Services In Medicare Advantage For 2023

A Further Breakdown Of Home-Based Care Services In Medicare Advantage For 2023

Ahead of the annual enrollment period Medicare Advantage (MA) organizations have been offering a peek into what benefits they’re offering seniors in 2023. Notably, many will give their beneficiaries access to home-based care services. Now, ATI Advisory is sharing exactly how many have made these services available to seniors. The number plans offering in-home support services has grown exponentially over […]

Why Healthcare Organizations Must Focus on Building Resilience Before a Crisis

Why Healthcare Organizations Must Focus on Building Resilience Before a Crisis

Eimer and many healthcare IT leaders across the country showed great resilience during the pandemic. The steps taken should be examined and built upon so that health systems can be proactive should more crises arrive, whether in the form of a pandemic surge, a cyberattack or a catastrophic weather event. As healthcare organizations look to improve their IT resilience, they […]

Oncology provider to go public via SPAC deal

Oncology provider to go public via SPAC deal

The co-founder and former co-CEO of insurer Oscar Health has identified a provider to take public through the special purpose acquisition company he leads.  American Oncology Network plans to go public through a combination with Digital Transformation Opportunities Corp., a blank-check company formed in early 2021 by CEO Kevin Nazemi and other executives in the healthcare and tech industries. The oncology provider […]

New study suggests benefits of colonoscopies may be overestimated

New study suggests benefits of colonoscopies may be overestimated

A new study from Europe has found that the benefits of regular colonoscopies in helping reduce the risk of colorectal cancer and death may have been overestimated due to gaps in evidence. The Nordic-European Initiative on Colorectal Cancer (NordICC) conducted a trial involving nearly 85,000 people between ages 55 and 64. The study sample included people from countries including Poland, […]

HCD Conference: 2022 Nightingale Awards Announced – HCD Magazine

HCD Conference: 2022 Nightingale Awards Announced – HCD Magazine

Healthcare Design magazine, in partnership with The Center for Health Design, announced the winners of the 2022 Nightingale Awards at the he Healthcare Design Conference + Expo in San Antonio. The annual Nightingale Awards, which recognizes products related to the healthcare built environment, are named for Florence Nightingale, a tireless advocate for the improvement of care and conditions in military and civilian hospitals in […]

Telemedicine regulation more aggressive now than before the pandemic?

Telemedicine regulation more aggressive now than before the pandemic?

Telemedicine exploded in popularity after COVID-19 hit, but limits are returning for care delivered across state lines. That complicates follow-up treatments for some cancer patients. It also can affect other types of care, including mental health therapy and routine doctor check-ins. Over the past year, nearly 40 states and Washington, D.C., have ended emergency declarations that made it easier for […]

Fauci: This is no time to let our guard down

Fauci: This is no time to let our guard down

Chief White House medical adviser Anthony Fauci on Monday warned that the U.S. should not ease up on its COVID-19 response as variants continue to circulate and as the country heads into the winter flu season.  “We have a ways to go, particularly as we enter the winter, which will be complicated by the influenza season. So there’s no time, ma’am, to […]

RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease – MedCity News

RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease – MedCity News

Ochre Bio co-founders Quin Wills, chief scientific officer (left), and Jack O’Meara, CEO (right). Photo by Business Wire.   A biotech startup developing RNA therapies for liver disease by running tests in live human livers has raised $30 million to identify a drug candidate to test in real live humans. Ochre Bio conducts its research with donor livers. These livers […]